Data sourced from SEC EDGAR filingsCompiled by Free Startup Funding DatabaseLast updated: 2022-01-21
SEC Form D Verified

Petrichor SCION Therapeutics

Venture Capital Firm | Contact, Fund History & Investment Focus

NEW YORK, NY
Stage Focus

series-a

Funds Tracked

1

Total Raised

$172M

Latest Fund

PETRICHOR SCION THERAPEUTICS LLC

Jan 2022 · $172M

How to Contact Petrichor SCION Therapeutics

Official Contact Channels

General Partners

AARON W. KANTOFF; TADD WESSEL; SAMUEL W. HALL

Best Practices for Reaching Out

  • Research their fund history to understand their investment thesis before reaching out
  • Connect with their team on LinkedIn for warm introductions when possible
  • Keep your initial outreach concise with clear traction metrics

Fund History

PETRICHOR SCION THERAPEUTICS LLC

Jan 2022 · series-a

$172M

New York's Venture Capital Ecosystem

New York City ranks second only to the San Francisco Bay Area for venture capital investment. The city's diverse economy spans fintech, media, e-commerce, and enterprise software.

Second largest VC market in U.S.
Fintech and media hub
Access to Fortune 500 clients
International gateway for startups
Explore all VC firms in New York

Frequently Asked Questions

How do I contact Petrichor SCION Therapeutics?

Visit Petrichor SCION Therapeutics's official website to find their contact information.

How many funds has Petrichor SCION Therapeutics raised?

Petrichor SCION Therapeutics has raised 1 tracked fund, totaling $172M in tracked capital.

What stage does Petrichor SCION Therapeutics invest in?

Petrichor SCION Therapeutics focuses on series-a investments.

Where is Petrichor SCION Therapeutics located?

Petrichor SCION Therapeutics is headquartered in NEW YORK, NY.

Firm Details

First FilingJan 2022
Latest FilingJan 2022

Data Sources: SEC EDGAR filings, company disclosures, and verified public records.

Last updated: Jan 21, 2022